NoRD Bio
NoRD Bio is a biotechnology company focused on transforming precision medicine through in-depth genomics. They offer advanced genomic technologies for deep insight into tumor biology, evolution, and treatment, specializing in Cell-free DNA (cfDNA) sequencing and analysis for treatment efficacy assessment, clonal evolution, and resistance dynamics. Their proprietary AI/ML computational platform, SmartRD, provides ultra-high sensitivity multi-modal liquid biopsy with unique epigenetic data. NoRD Bio partners with cancer therapeutics developers, from startups to pharmaceutical companies, leveraging their expertise in genome analysis, bioinformatics, and assay development to drive progress in cancer care. They have a strong team with academic and industry experience, including founders with backgrounds at the Broad Institute and Dana Farber Cancer Institute.
NoRD Bio
NoRD Bio is a biotechnology company focused on transforming precision medicine through in-depth genomics. They offer advanced genomic technologies for deep insight into tumor biology, evolution, and treatment, specializing in Cell-free DNA (cfDNA) sequencing and analysis for treatment efficacy assessment, clonal evolution, and resistance dynamics. Their proprietary AI/ML computational platform, SmartRD, provides ultra-high sensitivity multi-modal liquid biopsy with unique epigenetic data. NoRD Bio partners with cancer therapeutics developers, from startups to pharmaceutical companies, leveraging their expertise in genome analysis, bioinformatics, and assay development to drive progress in cancer care. They have a strong team with academic and industry experience, including founders with backgrounds at the Broad Institute and Dana Farber Cancer Institute.